Barbara Stella
Overview
Explore the profile of Barbara Stella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
953
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sturari S, Andreana I, Apra P, Bincoletto V, Kopecka J, Mino L, et al.
Nanoscale
. 2024 Jun;
16(24):11610-11622.
PMID: 38855987
Nanomedicine aims to develop smart approaches for treating cancer and other diseases to improve patient survival and quality of life. Novel nanoparticles as nanodiamonds (NDs) represent promising candidates to overcome...
2.
Andreana I, Chiapasco M, Bincoletto V, Digiovanni S, Manzoli M, Ricci C, et al.
Drug Deliv Transl Res
. 2024 May;
14(8):2100-2111.
PMID: 38709442
Biodegradable nanocarriers possess enormous potential for use as drug delivery systems that can accomplish controlled and targeted drug release, and a wide range of nanosystems have been reported for the...
3.
Andreana I, Bincoletto V, Manzoli M, Roda F, Giarraputo V, Milla P, et al.
Materials (Basel)
. 2023 Feb;
16(3).
PMID: 36770218
Biodegradable nanocarriers represent promising tools for controlled drug delivery. However, one major drawback related to their use is the long-term stability, which is largely influenced by the presence of water...
4.
Andreana I, Malatesta M, Lacavalla M, Boschi F, Milla P, Bincoletto V, et al.
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36613739
Muscular dystrophies are a group of rare genetic pathologies, encompassing a variety of clinical phenotypes and mechanisms of disease. Several compounds have been proposed to treat compromised muscles, but it...
5.
Calderan L, Carton F, Andreana I, Bincoletto V, Arpicco S, Stella B, et al.
Eur J Histochem
. 2022 Dec;
67(1).
PMID: 36546417
The development of novel nanoconstructs for biomedical applications requires the assessment of their biodistribution, metabolism and clearance in single cells, organs and entire organisms in a living environment. To reduce...
6.
Nicoletti L, Paoletti C, Tarricone G, Andreana I, Stella B, Arpicco S, et al.
Nanomedicine
. 2022 Jul;
45:102589.
PMID: 35908737
Design of nanocarriers for efficient miRNA delivery can significantly improve miRNA-based therapies. Lipoplexes based on helper lipid, dioleoyl phosphatidylethanolamine (DOPE) and cationic lipid [2-(2,3-didodecyloxypropyl)-hydroxyethyl] ammonium bromide (DE) were formulated to...
7.
Andreana I, Bincoletto V, Milla P, Dosio F, Stella B, Arpicco S
Drug Deliv Transl Res
. 2022 Feb;
12(8):1911-1927.
PMID: 35217992
Pentamidine (PTM), which is a diamine that is widely known for its antimicrobial activity, is a very interesting drug whose mechanism of action is not fully understood. In recent years,...
8.
Cannito S, Bincoletto V, Turato C, Pontisso P, Scupoli M, Ailuno G, et al.
Molecules
. 2022 Feb;
27(3).
PMID: 35164326
Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and is characterized by poor clinical outcomes, with the majority of patients not being eligible for curative therapy and treatments...
9.
Ozaydin Ince G, Coclite A, Stella B
Front Bioeng Biotechnol
. 2021 Nov;
9:782615.
PMID: 34722484
No abstract available.
10.
Argenziano M, Arpicco S, Brusa P, Cavalli R, Chirio D, Dosio F, et al.
Pharmaceutics
. 2021 Oct;
13(10).
PMID: 34683830
Active targeting is a valuable and promising approach with which to enhance the therapeutic efficacy of nanodelivery systems, and the development of tumor-targeted nanoparticles has therefore attracted much research attention....